# SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid7035222
Categories: beauty, cleaning, food, industrial, pharma
Functions: Anti-caking agent, Biocide, Drier, Emulsifier, Flavouring and nutrient, Fragrance, Humectant, Leavening agent, Other, pH regulating agent, Pharmaceutical, Poultry scald agents (must be removed by subsequent cleaning operations)
Identifier: DTXSID7035222

> SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS is used as anti-caking agent / biocide. EPA CPDat observed this chemical in 312 composition records across product categories including Construction and building materials, Laboratory supplies, Specialty occupational products. Assessed from 47 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 312 composition records across product categories including Construction and building materials, Laboratory supplies, Specialty occupational products.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 312 composition records across product categories including Construction and building materials, Laboratory supplies, Specialty occupational products. EPA CPDat classifies this chemical for functional uses including pH regulating agent, Pharmaceutical, Fragrance.
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: DROPS; Potency: 1.1 %w/w
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SOLUTION; Potency: 0.13 %w/w
- US: inactive ingredient database — Route: BUCCAL; Dosage form: FILM; Potency: 1.09 mg
- US: inactive ingredient database — Route: BUCCAL; Dosage form: FILM, SOLUBLE; Potency: 0.03 mg
- US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 13 mg
- US: inactive ingredient database — Route: INTRALESIONAL; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 10 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 13 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 18.81 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 161 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION; Potency: 0.62 %w/v
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 13 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 8 mg
- US: inactive ingredient database — Route: INTRAOCULAR; Dosage form: INSERT; Potency: 0.01 mg
- US: inactive ingredient database — Route: INTRASYNOVIAL; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 10 mg
- US: inactive ingredient database — Route: INTRAVASCULAR; Dosage form: INJECTION; Potency: 0.01 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 12.8 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 18.81 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 161 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Potency: 0.62 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: SOLUTION; Potency: 40 mg
- US: inactive ingredient database — Route: INTRAVESICAL; Dosage form: SOLUTION; Potency: 0.12 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 0.78 %w/v
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: 0.46 %w/v
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: 0.65 %w/w
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Potency: 0.44 %w/w
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 120 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 65 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SYRUP; Potency: 0.7 mg/1ml
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Potency: 4.18 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 23.4 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 62 mg
- US: inactive ingredient database — Route: SOFT TISSUE; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 13 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: 33.1 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 0.2 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 1.1 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Potency: 1 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 6 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: LOTION; Potency: 0.2 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SHAMPOO, SUSPENSION; Potency: 1 %w/v
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SOLUTION; Potency: 0.47 %w/v
- US: inactive ingredient database — Route: VAGINAL; Dosage form: CREAM; Potency: ADJ PH
- US: marketed drug occurrence — FDA NDC lists this ingredient in 2 active drug products and 2 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

_Assessed by Greenveil._